Pharmaceuticals · Pharmaceuticals: Major · NSE: CURIS · data 2026-10-30

Curis Lifesciences Limited

₹180-0.55% on 30 OctHealth: Strong 8.5/10

In plain words

Price: 23.3% below its 52-week high of ₹234.75.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹180

Market cap

₹146 cr

P/E

21.2

P/B

3.1

ROE

21.7%

ROCE

26.6%

Debt / equity

0.46

Dividend yield

0.00%

1-year return

23.2%

52-week high

₹234.75

52-week low

₹83.6

Operating margin

17.2%

Growth

Revenue (last 12 months)	₹61 cr
Net profit (last 12 months)	₹7 cr
Sales growth, 3 years (yearly)	19.6%
Profit growth, 3 years (yearly)	78.0%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Curis Lifesciences Limited debt-free?

Its latest reported debt-to-equity ratio is 0.46.

What is Curis Lifesciences Limited's P/E ratio?

About 21.2, based on the last 12 months' earnings and a price of ₹180 (data 2026-10-30).

What is the 52-week high and low of Curis Lifesciences Limited?

The 52-week high is ₹234.75 and the 52-week low is ₹83.6.

Similar companies

Medico Remedies Ltd. (MEDICO) · Quest Laboratories Ltd. (QUESTLAB) · Bal Pharma Limited (BALPHARMA) · Krebs Biochemicals & Industries Ltd. (KREBSBIO) · Parnax Lab Limited (PARNAXLAB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open CURIS in NSE Scanner →